MedPage Today on MSN
Similar prostate cancer drugs show different results in real-world study
Better short-term survival with apalutamide versus darolutamide, but lots of unanswered qu ...
The Express Tribune on MSN
Inmates smuggle drugs into Punjab jails by concealing them in sensitive body parts
Inmates in Punjab's jails have been smuggling narcotics by concealing them in sensitive parts of their bodies, the Punjab Prisons Department told the Lahore High Court in a disclosure submitted as ...
Scientists at the University of Virginia School of Medicine are chasing a new way to slow glioblastoma, the deadliest brain ...
During the Jan. 28 Alzheimer's Drug Discover Foundation lecture, panelists said the tests will revolutionize diagnosis and ...
About a million people experience overdoses in the U.S. every year. Nodding and overdose may both cause oxygen deprivation, ...
Overcoming tumor resistance to chemotherapy drugs has long been a challenge for oncology clinicians and researchers. Now, a new study suggests that blocking a key protein, p300, may force damaged ...
A Democratic congresswoman is pushing the federal government to consider “relaxing” strict drug testing rules for ...
New 2026 cannabis bills in Mississippi, Hawaii, and Nebraska reveal the next wave of drug testing challenges for employers.
Medical Device Network on MSN
AccuLine reports 94% sensitivity of AI CAD diagnostic in new trial readout
With the Israel-based trial of AccuLine’s CORA system complete, the company is now preparing to initiate a US trial to ...
FDA proposes MRD-negative and complete response endpoints to fast-track multiple myeloma drug approvals, pushing deeper molecular results over ORR.
Researchers recently tried an experiment: Gather people who had the same kind of lung cancer and put them on the same type of treatments to fire up their immune systems. The only difference was that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results